Two regulatory elements required for enhancing ospA expression in Borrelia burgdorferi grown in vitro but repressing its expression during mammalian infection.
During cycling between the tick vector and a mammal, the Lyme disease spirochaete Borrelia burgdorferi must coordinate expression of outer-surface proteins (Osps) A and B to quickly respond to environmental changes. The pathogen abundantly produces OspA/B in the tick, but represses their expression during mammalian infection. This paper reports a regulatory structure, consisting of two sequences flanking the ospAB promoter, that is required for enhancing ospA expression in B. burgdorferi grown in vitro, but repressing its expression during murine infection. Deletion or replacement of either the upstream or downstream sequence of the ospAB promoter caused a significant decrease in ospA expression in vitro, but a dramatic increase during murine infection. Fusion of either sequence with the flaB reporter promoter led to increased expression of an ospA reporter gene in vitro, but a decrease in the murine host. Furthermore, simultaneous fusion of both sequences with the reporter promoter showed a synergistic effect in enhancing expression of the ospA reporter in vitro, but repressing its expression during murine infection. Taken together, the results demonstrate that the regulatory structure functions oppositely in the two different environments and potentially provides B. burgdorferi with a molecular mechanism to quickly adapt to the distinct environments during its enzootic life cycle.
Xu
Qilong
Q
Department of Pathobiological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.
McShan
Kristy
K
Department of Pathobiological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.
Liang
Fang Ting
FT
Department of Pathobiological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.
D000818:Animals; D000954:Antigens, Surface / Q000235:genetics* / Q000378:metabolism; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D001428:Bacterial Vaccines / Q000235:genetics* / Q000378:metabolism; D025065:Borrelia burgdorferi / Q000235:genetics / Q000254:growth & development* / Q000378:metabolism; D015964:Gene Expression Regulation, Bacterial; D006801:Humans; D008074:Lipoproteins / Q000235:genetics* / Q000378:metabolism; D008193:Lyme Disease / Q000382:microbiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D011401:Promoter Regions, Genetic; D012045:Regulatory Sequences, Nucleic Acid
D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; C072045:OspA protein
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):670-5
11209063
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3142-7
14970347
Mol Microbiol. 2001 Feb;39(3):714-21
11169111
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13865-70
11106398
J Exp Med. 2002 Jul 15;196(2):275-80
12119353
PLoS Pathog. 2007 Mar;3(3):e33
17352535
J Bacteriol. 2004 Nov;186(21):7390-402
15489451
Mol Microbiol. 1999 Jul;33(1):41-51
10411722
J Exp Med. 1996 Jan 1;183(1):271-5
8551231
Mol Microbiol. 2007 Sep;65(5):1193-217
17645733
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12724-9
11675503
J Exp Med. 2004 Mar 1;199(5):641-8
14981112
Microbiology (Reading). 2008 Nov;154(Pt 11):3420-3429
18957595
J Bacteriol. 2007 Nov;189(22):8377-80
17873053
Infect Immun. 2008 Mar;76(3):1239-46
18195034
Int J Med Microbiol. 2007 Apr;297(2):97-107
17267282
Infect Immun. 1992 May;60(5):1845-53
1563773
Vector Borne Zoonotic Dis. 2001 Spring;1(1):65-74
12653137
Infect Immun. 2004 Oct;72(10):5759-67
15385475
Infect Immun. 2006 Jun;74(6):3547-53
16714587
Cell. 2004 Nov 12;119(4):457-68
15537536
Microb Pathog. 2004 Jul;37(1):35-40
15194158
Infect Immun. 1997 Aug;65(8):3146-50
9234767
Mol Microbiol. 2008 Jul;69(1):15-29
18452586
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2909-13
7708747
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18159-64
15608069
Mol Microbiol. 2008 Dec;70(6):1453-64
19019147
Int J Med Microbiol. 2006 May;296 Suppl 40:185-94
16530008
Infect Immun. 1986 Oct;54(1):207-12
3019889
Infect Immun. 2008 Nov;76(11):5228-37
18779341
J Bacteriol. 2006 Jul;188(13):4879-89
16788197
Infect Immun. 2005 Jun;73(6):3313-21
15908357
J Bacteriol. 2005 Nov;187(22):7845-52
16267308
Infect Immun. 1995 Apr;63(4):1573-80
7890424
Mol Microbiol. 2007 Apr;64(1):220-31
17376084
Mol Microbiol. 2003 May;48(3):753-64
12694619
Microbiol Rev. 1991 Sep;55(3):371-94
1943993
Infect Immun. 2007 Jun;75(6):2786-94
17371860
Microbiology (Reading). 2008 Jan;154(Pt 1):16-29
18174122
J Clin Invest. 2004 Jan;113(2):220-30
14722614
Infect Immun. 2005 Nov;73(11):7208-15
16239515
Infect Immun. 2007 Sep;75(9):4272-81
17562764
J Clin Microbiol. 2000 Jan;38(1):382-8
10618120